Alector Therapeutics’ novel Alzheimer’s strategy fails in Phase 2 trial
Alector Therapeutics, working with AbbVie, was testing whether modulating immune cells in brain would slow Alzheimer’s disease. Its drug failed the Phase 2 trial.
Related Articles
ACR24 – RHEUMATOID ARTHRITIS | RheumNow
A New ACR Cancer Survival in RA “Changing Mindsets about Methotrexate Side Effects” Control RA, Build Stronger Bones Cumulative Steroid Use and Cardiovascular Events Disease…
JAMA unveils channel devoted to health AI research, perspective
Health AI tools are rapidly gaining a foothold in medicine, but it takes rigorous research to uncover their impact and help physicians use them wisely.
Strict Disease Control Criteria Linked to Increased Work Productivity for Patients with PsA
This post-hoc analysis demonstrated an association between work productivity and stringent disease control criteria for those with psoriatic arthritis.
What Exactly Are Phthalates? And Are They Safe?
These chemicals can be found everywhere, from plastics to personal care products. Learn more about how they interact with your hormones and what you can…
Emerging mesenchymal tumour types and biases in the era of ubiquitous sequencing
New tumour types are being described at increasing frequency, and most new tumour types are now identified via retrospective review of next-generation sequencing data. This…
Only about 720,000 Qualcomm Snapdragon X laptops sold since launch — under 0.008% of the total number of PCs shipped over the period, or less than 1 out of every 125 devices
AI-capable PCs grow 49%, and take 20% of shipments, but Snapdragon X PCs struggle
How To Fix Lower Back Pain When Running
Does your back ache whenever you run? A physical therapist has some recommendations to make the hurt go away.
RSV Prevention in Infants: Promising Products, But at What Cost?
In this month’s issue of Pediatrics, Hutton et al present 2 important studies evaluating the health and economic impacts of maternal vaccination with the RSVpreF vaccine…
Anthropic launches tool to connect AI systems directly to datasets
Enabling AI agents that can access necessary data directly.
California sees surge in people moving to the state
California was the second most popular state for Americans to move to in 2024, according to a newly released report from the National Association of…